© Drug Hunter Inc. 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > “compound 34”
<< Back to October
oral PARP1-selective polymerase inhibitor
oral efficacy in BRCA1 mutant xenograft
from scaffold hopping from lit. PARP1/2 inh.
Bioorg. Med. Chem., Oct. 6, 2020
Lupin Ltd., Pune, IN
“compound 34” (Lupid oral in vivo PARP1-selective polymerase inhibitor)
Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.